Here are five things to know:
1. Michael A. McManus, Jr., will step down from his positions as director and chairman of the board of directors as well as president and CEO.
2. Stavros G. Vizirgianakis, a member of Misonix’s board of directors, will fill Mr. McManus’ place as the interim CEO.
3. Misonix is currently pursuing options with Mr. Vizirgianakis to fill the full-time position of CEO.
4. Mr. Vizirgianakis has served on the board since May 2013 and has a 5.7 percent ownership state in the company.
5. Misonix develops ultrasonic products for spine surgery, neurosurgery, wound debridement, skull base surgery and laparoscopic surgery, among other applications.
More articles on devices:
J&J, SI-BONE, Medtronic & more: 10 key notes
Global wearable health sensors market to hit $48.6M by 2018: 4 observations
Global orthopedic implants market to hit $6.2B by 2024 — 7 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
